Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. Pfizer and Amgen hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast period. Based on the drug class the market can be segmented into Beta blockers, ARBs, and ACE inhibitors. Angiotensin II receptor blockers (ARB) are a group of pharmaceuticals that modify the renin-angiotensin system. The heart disease drugs market is experiencing growth in the ARBs segment because it reduces the risk of death caused by heart failure and minimizes the chance of hospitalization of people with heart failure.
The latest trend gaining momentum in the market is investment inclination toward developing countries. Countries such as India, China, and Brazil are turning out to be some of the most attractive countries for pharmaceutical companies across the globe. Many factors such as huge share of global population and rising geriatric population are leading to the high growth of healthcare sector in the developing countries. In addition, the rising cases of lifestyle disorders such as obesity and diabetes also contribute to higher heart failure cases in the region.One of the major drivers for this market is rising geriatric population. A large number of health problems are associated with the rising age, and CVDs are major among them. As a person gets older, the blood vessels become less flexible, thus making it difficult for the blood to flow through them. Rising age accompanied by other factors such as lifestyle-oriented diseases and smoking increases the risk of CVDs, especially heart failure. Heart failure in the geriatric population will continue to be a rising health burden globally, as this population represents the majority of the heart failure patients. Hence, rising geriatric population drives the demand for heart failure drugs during the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Heart Failure Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Heart Failure Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Heart Failure Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline
Pfizer
Novartis
Amgen
AstraZeneca
Gilead
Bayer
Teva Pharmaceutical industries
By Type:
Beta Blockers
ARBs
ACE Inhibitors
By End-User:
Hospital
Pharmacy
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Heart Failure Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Heart Failure Drugs Market Size and Growth Rate of Beta Blockers from 2016 to 2027
-
1.3.2 China Heart Failure Drugs Market Size and Growth Rate of ARBs from 2016 to 2027
-
1.3.3 China Heart Failure Drugs Market Size and Growth Rate of ACE Inhibitors from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Heart Failure Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Heart Failure Drugs Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
1.4.3 China Heart Failure Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Heart Failure Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Heart Failure Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Beta Blockers
-
3.4.2 Market Size and Growth Rate of ARBs
-
3.4.3 Market Size and Growth Rate of ACE Inhibitors
4 Segmentation of Heart Failure Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Heart Failure Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Heart Failure Drugs in Hospital
-
4.4.2 Market Size and Growth Rate of Heart Failure Drugs in Pharmacy
-
4.4.3 Market Size and Growth Rate of Heart Failure Drugs in Others
5 Market Analysis by Regions
-
5.1 China Heart Failure Drugs Production Analysis by Regions
-
5.2 China Heart Failure Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Heart Failure Drugs Landscape Analysis
-
6.1 North China Heart Failure Drugs Landscape Analysis by Major Types
-
6.2 North China Heart Failure Drugs Landscape Analysis by Major End-Users
7 Central China Heart Failure Drugs Landscape Analysis
-
7.1 Central China Heart Failure Drugs Landscape Analysis by Major Types
-
7.2 Central China Heart Failure Drugs Landscape Analysis by Major End-Users
8 South China Heart Failure Drugs Landscape Analysis
-
8.1 South China Heart Failure Drugs Landscape Analysis by Major Types
-
8.2 South China Heart Failure Drugs Landscape Analysis by Major End-Users
9 East China Heart Failure Drugs Landscape Analysis
-
9.1 East China Heart Failure Drugs Landscape Analysis by Major Types
-
9.2 East China Heart Failure Drugs Landscape Analysis by Major End-Users
10 Northeast China Heart Failure Drugs Landscape Analysis
-
10.1 Northeast China Heart Failure Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Heart Failure Drugs Landscape Analysis by Major End-Users
11 Southwest China Heart Failure Drugs Landscape Analysis
-
11.1 Southwest China Heart Failure Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Heart Failure Drugs Landscape Analysis by Major End-Users
12 Northwest China Heart Failure Drugs Landscape Analysis
-
12.1 Northwest China Heart Failure Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Heart Failure Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 GlaxoSmithKline
-
13.1.1 GlaxoSmithKline Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer
-
13.2.1 Pfizer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Novartis
-
13.3.1 Novartis Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Amgen
-
13.4.1 Amgen Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 AstraZeneca
-
13.5.1 AstraZeneca Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Gilead
-
13.6.1 Gilead Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bayer
-
13.7.1 Bayer Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Teva Pharmaceutical industries
-
13.8.1 Teva Pharmaceutical industries Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Heart Failure Drugs Market Size and Growth Rate of Beta Blockers from 2016 to 2027
-
Figure China Heart Failure Drugs Market Size and Growth Rate of ARBs from 2016 to 2027
-
Figure China Heart Failure Drugs Market Size and Growth Rate of ACE Inhibitors from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Heart Failure Drugs Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Heart Failure Drugs Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
Figure China Heart Failure Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Heart Failure Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Heart Failure Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Heart Failure Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Heart Failure Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Heart Failure Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Beta Blockers
-
Figure Market Size and Growth Rate of ARBs
-
Figure Market Size and Growth Rate of ACE Inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Heart Failure Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Heart Failure Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Pharmacy
-
Figure Market Size and Growth Rate of Others
-
Table China Heart Failure Drugs Production by Regions
-
Table China Heart Failure Drugs Production Share by Regions
-
Figure China Heart Failure Drugs Production Share by Regions in 2016
-
Figure China Heart Failure Drugs Production Share by Regions in 2021
-
Figure China Heart Failure Drugs Production Share by Regions in 2027
-
Table China Heart Failure Drugs Consumption by Regions
-
Table China Heart Failure Drugs Consumption Share by Regions
-
Figure China Heart Failure Drugs Consumption Share by Regions in 2016
-
Figure China Heart Failure Drugs Consumption Share by Regions in 2021
-
Figure China Heart Failure Drugs Consumption Share by Regions in 2027
-
Table North China Heart Failure Drugs Consumption by Types from 2016 to 2027
-
Table North China Heart Failure Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Heart Failure Drugs Consumption Share by Types in 2016
-
Figure North China Heart Failure Drugs Consumption Share by Types in 2021
-
Figure North China Heart Failure Drugs Consumption Share by Types in 2027
-
Table North China Heart Failure Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Heart Failure Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Heart Failure Drugs Consumption Share by End-Users in 2016
-
Figure North China Heart Failure Drugs Consumption Share by End-Users in 2021
-
Figure North China Heart Failure Drugs Consumption Share by End-Users in 2027
-
Table Central China Heart Failure Drugs Consumption by Types from 2016 to 2027
-
Table Central China Heart Failure Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Heart Failure Drugs Consumption Share by Types in 2016
-
Figure Central China Heart Failure Drugs Consumption Share by Types in 2021
-
Figure Central China Heart Failure Drugs Consumption Share by Types in 2027
-
Table Central China Heart Failure Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Heart Failure Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Heart Failure Drugs Consumption Share by End-Users in 2016
-
Figure Central China Heart Failure Drugs Consumption Share by End-Users in 2021
-
Figure Central China Heart Failure Drugs Consumption Share by End-Users in 2027
-
Table South China Heart Failure Drugs Consumption by Types from 2016 to 2027
-
Table South China Heart Failure Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Heart Failure Drugs Consumption Share by Types in 2016
-
Figure South China Heart Failure Drugs Consumption Share by Types in 2021
-
Figure South China Heart Failure Drugs Consumption Share by Types in 2027
-
Table South China Heart Failure Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Heart Failure Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Heart Failure Drugs Consumption Share by End-Users in 2016
-
Figure South China Heart Failure Drugs Consumption Share by End-Users in 2021
-
Figure South China Heart Failure Drugs Consumption Share by End-Users in 2027
-
Table East China Heart Failure Drugs Consumption by Types from 2016 to 2027
-
Table East China Heart Failure Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Heart Failure Drugs Consumption Share by Types in 2016
-
Figure East China Heart Failure Drugs Consumption Share by Types in 2021
-
Figure East China Heart Failure Drugs Consumption Share by Types in 2027
-
Table East China Heart Failure Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Heart Failure Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Heart Failure Drugs Consumption Share by End-Users in 2016
-
Figure East China Heart Failure Drugs Consumption Share by End-Users in 2021
-
Figure East China Heart Failure Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Heart Failure Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Heart Failure Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Heart Failure Drugs Consumption Share by Types in 2016
-
Figure Northeast China Heart Failure Drugs Consumption Share by Types in 2021
-
Figure Northeast China Heart Failure Drugs Consumption Share by Types in 2027
-
Table Northeast China Heart Failure Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Heart Failure Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Heart Failure Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Heart Failure Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Heart Failure Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Heart Failure Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Heart Failure Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Heart Failure Drugs Consumption Share by Types in 2016
-
Figure Southwest China Heart Failure Drugs Consumption Share by Types in 2021
-
Figure Southwest China Heart Failure Drugs Consumption Share by Types in 2027
-
Table Southwest China Heart Failure Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Heart Failure Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Heart Failure Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Heart Failure Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Heart Failure Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Heart Failure Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Heart Failure Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Heart Failure Drugs Consumption Share by Types in 2016
-
Figure Northwest China Heart Failure Drugs Consumption Share by Types in 2021
-
Figure Northwest China Heart Failure Drugs Consumption Share by Types in 2027
-
Table Northwest China Heart Failure Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Heart Failure Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Heart Failure Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Heart Failure Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Heart Failure Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Gilead
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead
-
Figure Sales and Growth Rate Analysis of Gilead
-
Figure Revenue and Market Share Analysis of Gilead
-
Table Product and Service Introduction of Gilead
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Teva Pharmaceutical industries
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical industries
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical industries
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical industries
-
Table Product and Service Introduction of Teva Pharmaceutical industries
-
